Share Prices & Company Research

Market News

21 May 2019 | 08:37

Mercia Technologies invests an additional £2m in Medherant

Investment group Mercia Technologies said it had made an additional £2.0m direct investment in pain and central nervous system product developer Medherant.

The investment was made as part of a £2.4m syndicated investment round.

Medherant was a clinical-stage company developing products using a unique transdermal delivery technology.

At 8:37am: (LON:MERC) Mercia Technologies Plc share price was 0p at 35p

Story provided by
Get in touch today
Join Redmayne Bentley
Talk to us now about opening a new account or transferring your account from another provider
0113 243 6941
Get in touch today
Contact your local office
Contact your local office to find out more
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.